US Patent 10406199 Lisinopril formulations
Patent 10406199 was granted and assigned to Silvergate Pharmaceuticals, Inc. on September, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 7, 2019
Date of Patent
September 10, 2019
Patent Applicant
Patent Application Number
16295482
Patent Citations
Patent Citations Received
Patent Inventor Names
David W. Miles
0
Gerold L. Mosher
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10406199 Lisinopril formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
